DGX — Quest Diagnostics
Data coverage, completeness and provenance for Quest Diagnostics in the Stock Market API — Health Care · Diagnostics & Research.
Stored price coverage
Source date: 2026-11-19T21:02:40. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-19 | 259.0900 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 259.6900 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 256.3500 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 262.2100 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-13 | 259.6000 | USD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/DGX/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Profile
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Employees: 60,000 · Website: https://www.questdiagnostics.com · Profile fields populated: 75%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/DGX/financials.
Financial statement coverage (USD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (USD) | 2025-12-31 | 28 | sec_edgar | ||||
| FY2024 (USD) | 2024-12-31 | 28 | sec_edgar | ||||
| FY2023 (USD) | 2023-12-31 | 29 | sec_edgar | ||||
| FY2022 (USD) | 2022-12-31 | 29 | sec_edgar | ||||
| FY2021 (USD) | 2021-12-31 | 29 | sec_edgar |
Get DGX data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/DGX
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/DGX/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/DGX/metrics/summary
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/DGX/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/DGX
Query DGX programmatically
Free tier — instant API key. Built for AI agents.
Other NYSE · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for DGX?
- Stored coverage for DGX: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/DGX; inspect available source metadata for provenance.
- How complete is DGX's financial data?
- The anchor reporting period (FY2025) has 94.1% of the 17 core statement fields populated. Primary source: sec_edgar.
- What reporting periods are covered for DGX?
- 5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/DGX/financials.
- Where does DGX's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/DGX/financials; missing tags do not establish provenance.